Safety and Efficacy Study of GoldenFlow Peripheral Stent System
Safety and Efficacy Study of GoldenFlow Peripheral Stent System, A Prospective, Multi-center, Single-Arm Clinical Trial
Sponsor: Lifetech Scientific (Shenzhen) Co., Ltd.
Listed as NCT03687983, this NA trial focuses on Femoral Artery Occlusion and Femoral Artery Stenosis and remains ongoing. Sponsored by Lifetech Scientific (Shenzhen) Co., Ltd., it has been updated 5 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status NA
-
Oct 2020 — Jan 2021 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Oct 2018 — Oct 2020 [monthly]
Recruiting NA
First recorded
May 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Lifetech Scientific (Shenzhen) Co., Ltd.
For direct contact, visit the study record on ClinicalTrials.gov .